TW200810786A - Oral compositions comprising siloxane polymers - Google Patents
Oral compositions comprising siloxane polymers Download PDFInfo
- Publication number
- TW200810786A TW200810786A TW096115215A TW96115215A TW200810786A TW 200810786 A TW200810786 A TW 200810786A TW 096115215 A TW096115215 A TW 096115215A TW 96115215 A TW96115215 A TW 96115215A TW 200810786 A TW200810786 A TW 200810786A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- agent
- composition
- oral
- polymer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 129
- 229920000642 polymer Polymers 0.000 title claims abstract description 69
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 51
- -1 fluoride ions Chemical class 0.000 claims abstract description 23
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 9
- 239000011574 phosphorus Substances 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 40
- 150000001875 compounds Chemical class 0.000 claims description 27
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 15
- 230000002882 anti-plaque Effects 0.000 claims description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 13
- 239000001301 oxygen Substances 0.000 claims description 13
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- 208000006558 Dental Calculus Diseases 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- 235000021317 phosphate Nutrition 0.000 claims description 10
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 8
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 8
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 6
- 230000000181 anti-adherent effect Effects 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 6
- 150000003904 phospholipids Chemical class 0.000 claims description 6
- 210000003296 saliva Anatomy 0.000 claims description 6
- 239000003765 sweetening agent Substances 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 229940035676 analgesics Drugs 0.000 claims description 5
- 239000000730 antalgic agent Substances 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 230000003239 periodontal effect Effects 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 241000894007 species Species 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 239000004014 plasticizer Substances 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 150000001336 alkenes Chemical class 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000002269 analeptic agent Substances 0.000 claims description 3
- 239000003911 antiadherent Substances 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 239000004075 cariostatic agent Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- 230000002087 whitening effect Effects 0.000 claims description 3
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 claims description 2
- 229940090898 Desensitizer Drugs 0.000 claims description 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 235000008160 pyridoxine Nutrition 0.000 claims description 2
- 239000011677 pyridoxine Substances 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 239000000021 stimulant Substances 0.000 claims description 2
- 239000004575 stone Substances 0.000 claims description 2
- 239000007852 tooth bleaching agent Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 2
- 241000209094 Oryza Species 0.000 claims 2
- 235000007164 Oryza sativa Nutrition 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000007800 oxidant agent Substances 0.000 claims 2
- 235000009566 rice Nutrition 0.000 claims 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 2
- IPFDTWHBEBJTLE-UHFFFAOYSA-N 2h-acridin-1-one Chemical compound C1=CC=C2C=C3C(=O)CC=CC3=NC2=C1 IPFDTWHBEBJTLE-UHFFFAOYSA-N 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000266847 Mephitidae Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 claims 1
- 239000003975 dentin desensitizing agent Substances 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000003607 modifier Substances 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 150000003014 phosphoric acid esters Chemical class 0.000 claims 1
- 235000013599 spices Nutrition 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- 210000000214 mouth Anatomy 0.000 description 21
- 239000010408 film Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 125000000129 anionic group Chemical group 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 229940051866 mouthwash Drugs 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 229940083542 sodium Drugs 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920000388 Polyphosphate Polymers 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000002272 anti-calculus Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000001205 polyphosphate Substances 0.000 description 3
- 235000011176 polyphosphates Nutrition 0.000 description 3
- 229910052707 ruthenium Inorganic materials 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- QADHLRWLCPCEKT-UHFFFAOYSA-N Androstenediol Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)O)C4C3CC=C21 QADHLRWLCPCEKT-UHFFFAOYSA-N 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000007673 Origanum vulgare Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- QADHLRWLCPCEKT-LOVVWNRFSA-N androst-5-ene-3beta,17beta-diol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC=C21 QADHLRWLCPCEKT-LOVVWNRFSA-N 0.000 description 2
- 229950009148 androstenediol Drugs 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 230000000675 anti-caries Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 150000001767 cationic compounds Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000005702 oxyalkylene group Chemical group 0.000 description 2
- 230000007505 plaque formation Effects 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SMOHSULBMKXDEN-RVDMUPIBSA-N (e)-1-n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitro-1-n'-prop-2-ynylethene-1,1-diamine Chemical compound CN(C)CC1=CC=C(CSCCN\C(NCC#C)=C\[N+]([O-])=O)O1 SMOHSULBMKXDEN-RVDMUPIBSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 1
- KEDVUOWPLAHMLZ-UHFFFAOYSA-N 1-cyano-3-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]-2-prop-2-ynylguanidine Chemical compound CC=1NC=NC=1CSCCNC(NC#N)=NCC#C KEDVUOWPLAHMLZ-UHFFFAOYSA-N 0.000 description 1
- YDDXVAXDYKBWDX-UHFFFAOYSA-N 1-cyano-3-[2-[[2-(diaminomethylideneamino)-4-thiazolyl]methylthio]ethyl]-2-methylguanidine Chemical compound N#CNC(=NC)NCCSCC1=CSC(N=C(N)N)=N1 YDDXVAXDYKBWDX-UHFFFAOYSA-N 0.000 description 1
- QYXHFICHKVRPSH-UHFFFAOYSA-N 1-cyano-3-[4-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]butyl]-2-methylguanidine Chemical compound N#CN=C(NC)NCCCCC1=CSC(NC(N)=N)=N1 QYXHFICHKVRPSH-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GEZAUFNYMZVOFV-UHFFFAOYSA-J 2-[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetan-2-yl)oxy]-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetane 2-oxide Chemical compound [Sn+2].[Sn+2].[O-]P([O-])(=O)OP([O-])([O-])=O GEZAUFNYMZVOFV-UHFFFAOYSA-J 0.000 description 1
- GIMNAEMRNXUAQP-UHFFFAOYSA-N 2-[4-(2-methyl-1h-imidazol-5-yl)-1,3-thiazol-2-yl]guanidine Chemical compound N1C(C)=NC=C1C1=CSC(N=C(N)N)=N1 GIMNAEMRNXUAQP-UHFFFAOYSA-N 0.000 description 1
- JDKAFLSRQPKFCQ-UHFFFAOYSA-N 2-[4-[2-[(4-amino-1-oxo-1,2,5-thiadiazol-3-yl)amino]ethylsulfanylmethyl]-1,3-thiazol-2-yl]guanidine Chemical compound S1C(N=C(N)N)=NC(CSCCNC=2C(=NS(=O)N=2)N)=C1 JDKAFLSRQPKFCQ-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- CQMNNMLVXSWLCH-UHFFFAOYSA-B 2-hydroxypropane-1,2,3-tricarboxylate;tin(4+) Chemical compound [Sn+4].[Sn+4].[Sn+4].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O CQMNNMLVXSWLCH-UHFFFAOYSA-B 0.000 description 1
- SKEZDZQGPKHHSH-UHFFFAOYSA-J 2-hydroxypropanoate;tin(4+) Chemical compound [Sn+4].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O SKEZDZQGPKHHSH-UHFFFAOYSA-J 0.000 description 1
- WVGYMZCCBWWQKT-UHFFFAOYSA-N 3-amino-1-chloro-1-(dichloroamino)urea Chemical compound ClN(N(Cl)Cl)C(=O)NN WVGYMZCCBWWQKT-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ALCSGJCIESECFD-UHFFFAOYSA-N 5-[3-[[amino(2,2,2-trifluoroethylimino)methyl]amino]-1-pyrazolyl]pentanamide Chemical compound NC(=O)CCCCN1C=CC(NC(N)=NCC(F)(F)F)=N1 ALCSGJCIESECFD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 229930195573 Amycin Natural products 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-N Arsenic acid Chemical compound O[As](O)(O)=O DJHGAFSJWGLOIV-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001600609 Equus ferus Species 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102100031416 Gastric triacylglycerol lipase Human genes 0.000 description 1
- 108091020100 Gingipain Cysteine Endopeptidases Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KMZQAVXSMUKBPD-DJWKRKHSSA-N Lafutidine Chemical compound C=1C=COC=1C[S+]([O-])CC(=O)NC\C=C/COC(N=CC=1)=CC=1CN1CCCCC1 KMZQAVXSMUKBPD-DJWKRKHSSA-N 0.000 description 1
- NRIGRKAXOLMTSK-UHFFFAOYSA-N Lamtidine Chemical compound CN1N=C(N)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 NRIGRKAXOLMTSK-UHFFFAOYSA-N 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- GBBDVMJBRZSBRW-UHFFFAOYSA-N OC=O.CCOC(N)=O Chemical compound OC=O.CCOC(N)=O GBBDVMJBRZSBRW-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 208000018087 Orbital disease Diseases 0.000 description 1
- 235000010677 Origanum vulgare Nutrition 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 1
- 240000002609 Pyrus pyrifolia var. culta Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000750042 Vini Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- FJFKYJKLMACIHF-UHFFFAOYSA-N [C].NC1=CC=CC=C1 Chemical compound [C].NC1=CC=CC=C1 FJFKYJKLMACIHF-UHFFFAOYSA-N 0.000 description 1
- NBVZMBLJRHUOJR-UHFFFAOYSA-N [amino-[4-[6-[4-[amino(azaniumylidene)methyl]phenoxy]hexoxy]phenyl]methylidene]azanium;2-hydroxyethanesulfonate Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 NBVZMBLJRHUOJR-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 229940000488 arsenic acid Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 229950002342 bisfentidine Drugs 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- JWVAUCBYEDDGAD-UHFFFAOYSA-N bismuth tin Chemical compound [Sn].[Bi] JWVAUCBYEDDGAD-UHFFFAOYSA-N 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- 229940041134 calcium glycerylphosphate Drugs 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical class CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- XSWSEQPWKOWORN-UHFFFAOYSA-N dodecan-2-ol Chemical compound CCCCCCCCCCC(C)O XSWSEQPWKOWORN-UHFFFAOYSA-N 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229950010956 donetidine Drugs 0.000 description 1
- MURUHMTVTKOWBY-UHFFFAOYSA-N donetidine Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(NC1=O)=NC=C1CC1=CC(=O)NC=C1 MURUHMTVTKOWBY-UHFFFAOYSA-N 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- ZQHFZHPUZXNPMF-UHFFFAOYSA-N ebrotidine Chemical compound S1C(N=C(N)N)=NC(CSCCN=CNS(=O)(=O)C=2C=CC(Br)=CC=2)=C1 ZQHFZHPUZXNPMF-UHFFFAOYSA-N 0.000 description 1
- 229950002377 ebrotidine Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229950007285 etintidine Drugs 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000009647 facial growth Effects 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 150000002241 furanones Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 108010091264 gastric triacylglycerol lipase Proteins 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000011874 heated mixture Substances 0.000 description 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229960001715 hexamidine isethionate Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- MURRAGMMNAYLNA-UHFFFAOYSA-N impromidine Chemical compound N1C=NC(CSCCNC(N)=NCCCC=2NC=NC=2)=C1C MURRAGMMNAYLNA-UHFFFAOYSA-N 0.000 description 1
- 229950005073 impromidine Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003303 lafutidine Drugs 0.000 description 1
- 229950003849 lamtidine Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229960003803 meclofenamic acid Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 229940095518 mouthwash product Drugs 0.000 description 1
- CPQCBGMVDITBNW-UHFFFAOYSA-N n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1,1-dioxothieno[3,4-d][1,2]thiazol-3-amine Chemical compound O1C(CN(C)C)=CC=C1CSCCNC1=NS(=O)(=O)C2=CSC=C12 CPQCBGMVDITBNW-UHFFFAOYSA-N 0.000 description 1
- HIVRCMFJEMKPDS-UHFFFAOYSA-N n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-oxidopyridin-1-ium-3-carboxamide Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(=O)C1=CC=C[N+]([O-])=C1 HIVRCMFJEMKPDS-UHFFFAOYSA-N 0.000 description 1
- HJZUEASXFDHGDQ-UHFFFAOYSA-N n-[3-[3-[(3-methylpiperidin-1-yl)methyl]phenoxy]propyl]-1-oxidopyridin-1-ium-3-carboxamide Chemical compound C1C(C)CCCN1CC1=CC=CC(OCCCNC(=O)C=2C=[N+]([O-])C=CC=2)=C1 HJZUEASXFDHGDQ-UHFFFAOYSA-N 0.000 description 1
- FXJAOWANXXJWGJ-UHFFFAOYSA-N n-[4-(2-methyl-1h-imidazol-5-yl)phenyl]-n'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=C(C)N1 FXJAOWANXXJWGJ-UHFFFAOYSA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- 125000003431 oxalo group Chemical group 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 150000004175 parthenolide derivatives Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- XCOJIVIDDFTHGB-YRNVUSSQSA-N perilla sugar Chemical compound CC(=C)C1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-YRNVUSSQSA-N 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 150000003021 phthalic acid derivatives Chemical class 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229950010771 ramixotidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- JEYKZWRXDALMNG-UHFFFAOYSA-N sufotidine Chemical compound CN1N=C(CS(C)(=O)=O)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 JEYKZWRXDALMNG-UHFFFAOYSA-N 0.000 description 1
- 229950002504 sufotidine Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000271 synthetic detergent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- YJBKVPRVZAQTPY-UHFFFAOYSA-J tetrachlorostannane;dihydrate Chemical compound O.O.Cl[Sn](Cl)(Cl)Cl YJBKVPRVZAQTPY-UHFFFAOYSA-J 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229910001432 tin ion Inorganic materials 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 229950011533 tiotidine Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LORRXSUXWWGUIX-UHFFFAOYSA-J tri(propanoyloxy)stannyl propanoate Chemical compound [Sn+4].CCC([O-])=O.CCC([O-])=O.CCC([O-])=O.CCC([O-])=O LORRXSUXWWGUIX-UHFFFAOYSA-J 0.000 description 1
- YJGJRYWNNHUESM-UHFFFAOYSA-J triacetyloxystannyl acetate Chemical compound [Sn+4].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O YJGJRYWNNHUESM-UHFFFAOYSA-J 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- PQGFRBOHUKOXQZ-FSCNPAMSSA-J tris[[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyl]oxy]stannyl (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Sn+4].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O PQGFRBOHUKOXQZ-FSCNPAMSSA-J 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229950003675 zaltidine Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- OXCRJCXSFXJLFS-UHFFFAOYSA-N zinc;dihypochlorite Chemical compound [Zn+2].Cl[O-].Cl[O-] OXCRJCXSFXJLFS-UHFFFAOYSA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
- B65D83/16—Actuating means
- B65D83/20—Actuator caps
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Cosmetics (AREA)
- Silicon Polymers (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
200810786 九、發明說明: Μ關申請案之夺亙參照 專^申申明案主張2006年5月1日申請之美國暫時 3 y案弟60/796,384號之權益,其之内容併入本文作 【發明所屬之技術領域】 一個親水
提供一種口用組成物,其包含一種含有具至少 區之石夕氣烧聚合物之活性成分。 【先前技術】 一 [0002]牙菌斑或牙菌斑生物膜為—種在牙齒上所形成 畜積物’且意味著牙齦炎、牙周病、鶴齒及其 犬 的發生。牙®斑生減提供牙結石或酒石形成之 填酸狀晶體被蓄積㈣驗利斑生物狀胞外基/中2 於牙齒上形成之硬質礦質化固體,且變成結晶之經基】 儘管規律的刷牙㈣於避免料蓄積之快速堆積,但即頻 律的刷牙仍不足以去除附著於牙齒之所有的牙結石蓄積物。 [0003] 許多抗菌劑已被發現具有抑制細菌生長之 能力,因而具有減輕牙菌斑形成、口部感染及與其有: 病之能力。然;而,許多抗菌劑與其他σ部活性成 容 或不穩定’難以在活體内遞送,或使其他期望之額外的: =ϊί分失活。一些抗菌劑很難於口用組成物中調配或 [0004] ㈣藉使用一種穩定的抗牙菌斑及/或抗酒石活 5 200810786 性劑來發展高度有效之口用組成物, 成,以及其他有害的口内健二症:或對抗牙菌斑形 效降低Π内疾病發生或進展之口用護理==亟須一種可有 藉預防或降低可促成及人或惡化 病因以減低口内疾病影響之活性成分。另外,亟;二
===::用組成物中’使得彼等當被遞送 ΐ :Γ容;尋之功用及生物可一 且非企圖限制本發 [0005]以下說明於本質上僅為例示 明之内容、應用或使用。 _6]於許多具體例中,口用護理組成物被供以—種活性 f分’其包種提供許多口㈣理利益(諸如抗牙菌斑效果 ’酉,控制等)之⑪氧絲合物。”⑪氧絲合物”指的是具 f和氧之基本骨架’帶有可為相同或不同之侧面構成基之聚合 籲物’ 一般以結構重覆單元(_〇_SiRR’_)n予以描述,其中尺及化 可為相同或不同之側面構成基,且η可為2以上之任意數值, 代表聚合物骨架中SRU之重覆性1氧㈣合物於此技蔽中 亦熟知為”矽酮”聚合物。矽氧烷聚合物可包括聚異質矽氧=, 其中側基及/或結構重覆單元可為不同之分子(具有不同^構 成基)’諸如名義上 SRU 式,(_〇_SiRRiV(_〇_Si R”R”,_)m (其 中R及R’為不同於R”及R”’之侧基且m為整數)所述^石夕氧 燒,-聚合物。此外,R及R’可互為不同;同樣地,R”及R,,, 亦是如此。此種矽氧烷聚合物可以各種端基予以終結,諸如二 200810786 F基矽基((CH3)3Si)終結之 炫。通常,_合物例===終㈣氧 和基與氫化物基图反應)令被交聯。、"令乙稀性不飽 [0007]傳統之聚有機矽取入 氧烷聚合物。於許多具體 二-親水區之石夕 性部分,諸如氧化稀類、二含-或多種親水 中,親水區包括含磷之部分:團。於某些具體例 酸醋、職、鱗脂等,將更 點,用二=:ΐ:部例如磷 :。於某些具體例中’院基經選擇為甲基 中,氧μ合物包含-種具有餐_ 例 广於某些具體例中,彻聚合物二甲上:=。 義通式(I)之化合物: 種根據名 ch3 ch3 ch3 ch3 H3c—SiO^Si-Oj^Si-O)^;—Si一CHa CH3 CH3 —R2 ch3 其中Ri係選自由:烷基、芳基、醯胺基、酯、吡: ^基:丙稀酸醋基、石夕氧燒、胺基甲酸酿、碳酸^乙 广、乳化烯及其之組合所成組群中;R2包含 喊醋、膦酸醋、填脂、含鱗酸醋基團及其之組合戶 =組 200810786 群中之部分。於某些具體例中,Ri絲及/或芳基之範圍 為(CrC^,且於一些具體例中具有低級烷基/芳基,例如 f有C2-Cl0,選擇性地由Q-C:6。於某些具體例中,氧化烯 範圍為C2-C4’因此包括氧化乙烯、氧化丙烯及氧化丁婦, 其中可提供複數基團。”x”範圍由〇至1〇〇,"y•,由!至
、[〇〇1〇]於某些具體例中,Ri包含_(CH2)V-(Q)Z,其中Q
$至J 一基團,選自:具有C2_C3之氧化烯,諸如〔2氏〇 或 c3H〇6o ; CH2CH(〇H) ; C0NH、C〇2、NH、c〇NH、
及 ^=7 ,其中V及Z分別為1至16。 =可選自 ρ〇3Η2、ρ〇3κ2、p〇挪叫Li2 及 p〇卿4)2, k自蛳脂,諸如磷酯醯基膽鹼,磷脂酸、磷脂醯肌醇、構 脂臨乙醇胺等。 [〇〇 11 ]適§之矽氧烧聚合物被描述於比等人之美屋 =利案 5:530,084 ;均㈣Lenick 之 5,〇7〇,171 及 6,175卿 :ey等人之6 124 49〇;全為触等人之㈣,彻 ,上,313 及 5,688,496 ;及 imperante 等人之 5,859,161 中。言 月中所引述之所有參考文獻,包括上述者,全部内i 特別併入本文作為參考。 人^2]於—些具體例中,具有含石粦酸酯部分之石夕氧烧驾 °匕含一種被揭示於美國專利案5,07(U71中之二曱基聋 元醇•㈣:此等石夕氧烧聚合物具有懸垂々 '此土且係藉含每基石夕酮與一種碟酸化藥劑反J 于以製備。 # 8 200810786 [0013]於某些具體例中,包含磷酸酯部分之矽氧燒聚合 物為一種具有式(II)之化合物: ch3 ch3 ch3 CH3 H3C—SiO-fSi-O^Si-O)-Si—CH3
I x I y y I ch3 ch3 ch3 (II) a(OC2H4)(〇C3H6)—R2 其中R2為一懸垂之磷酸酯基,諸如-P03H2或_((:Η3(:Η2;Η30) Ρ03Η2,”Χ”為 〇 至 1〇〇,”7”為 i 至 1〇〇,”m”為 〇 至 ^。3 於1 其他具體例中,矽氧烷聚合物包含至少一個磷酸酯基和至 少一個胺基。包含磷酸酯作為含磷部分之矽氧烧聚合物之 適當化合物具有式(III): ch3
CH3 ch3 ch3 I I /SiOCH3
3m<、CH3"
CH3 〇Ha CHrCHrCH2-N
R3、 /N (III) /、中尺3具有範圍Ci至c50之烧基,"x"為Q至, 1至100。於一些具體例中,R3w18烧基。 u 包人=4]適口用於口内護理及/或個人護理組成物中之 之外邓77之矽氧烷聚合物之非限制性實例包括磷酸化 虱烷聚合物,其可得自somerville(紐澤西,美國)之 9 200810786
Phoenix Chemical 之商品 PECOSIL® PS-100 (二甲基聚石夕氧烧 聚乙二醇(PEG-7)磷酸酯)、PS-200 (二曱基聚矽氧烷聚乙二 醇(PEG-10)磷酸酯)、WDS-100 (二甲基聚矽氧烷聚乙二醇 /聚丙二醇(PEG/PPG-7/4)磷酸酯)、WDS-200 (二曱基聚矽 氧烷聚乙二醇/聚丙二醇(PEG/PPG-12/4)磷酸酯)及 PECOSIL® PSQ-418(硬月旨醯二銨羥基丙基PEG-7二曱基聚矽 氧烷)。 [0015] 此等商業上可得之磷酸化矽氧烷聚合物通常具 有下列結構式(IV): ch3
9H3 9H3 ?H3 I I I I /SiCH3 H3C—SiO^ShO^Si-O^y \H3 CH3 CH3 C3H60R5P03H2 (IV) 其中R5為(C2H40)a,其中"an係根據期望之乙二醇(PEG)鏈 長/期望之分子量而變動,而PECOSIL® WDS-100及WDS-200為(CH3C2H30)b(C2H40)c,其中及”cn係分別根據選擇之 丙二醇(PPG)及乙二醇(PEG)之鏈長而變動。此通類之聚合 物具有由0至100之πχπ及1至100的”y”。 [0016] 另一種可用作口用組成物之活性成分之具有包括含 磷部分之親水區之矽氧烷聚合物為亞麻油醯胺基丙基PG-二 氣化銨(dimonium chloride)璃酸醋二曱基聚石夕氧烧,可得自美 國達拉威州威明頓市Uniqema股份有限公司之商品 MONASIL™ PLN (亦可以ARLASILK™磷脂PLN形式取得)。 此聚合物具有前述式III所示之結構,且此通類之聚合物於某 200810786 些具體例中包括代表C〗8之尺3, 〇至1〇〇之”χ,,及1至1〇〇之”” [0017]於一些具體例中,矽氧烷聚合物之親水區包 或多個親水基,諸如氧化烯類及/或胺類,其中矽氧俨取 合物包含具有式(V)之化合物: 4 + ch3 CH3 ch2 CH, ,SiCH3 \ CH, h3c—丨·〇〆 CH3 CH3 C3H60(C2H40)m(CH3C2H3〇)nR, (V) 其中R4係選自H或-P〇3H2,,,x’,為〇至1〇〇,,,y,,為j至 且”m”為〇至15,及”n”為〇至15。例如,具有R4經選擇 為Η之矽乳烷聚合物可得自美國密西根中陸道康寧公 販售之DC_190。其他適當之具有親水區之碎氧院聚合物可 得自吳國密西根中陸道康寧公司之商品DCM93 (聚乙 基聚石夕^共聚物或PEG_12二曱基聚秒氧烧)及dc-湖 (帶有氧化乙烯及/或氧化丙烯之⑨氧基化 性劑)。 取W法 [0018]力許多具體例中,包含至少一個親水區之 聚合物據信可充作一種抗附著劑或抗黏附劑。雖不二 本發明’但抗附著之口内護理活性成分咸信可藉兩個主要 (p ))為—種在口腔表® (通常在硬組織表面)上报 成^基質’其包含細菌(通常為生物基質之約60-70%/ 細菌胞外副產物、蛋白質、脂質及糖脂。術語”π腔表面” 包含口腔内部之硬及軟組織。硬組織包括牙齒、牙周支標 200810786 體等。軟組織包含牙酿、舌頭、頰腔之 :之口用組成物可被用於哺乳動物對象;,:二= 其他溫血高等脊椎動物,諸如貓及犬。八匕括人類及 [0019]不受理論之限制,相 -最初之細菌層,其附著至口腔表之早期包括 附素予以附著至與口表面上 作°错配位體或黏 卜。/士 4 Z 又互作用之細菌細胞壁 上據#細函細胞附著至口腔表面上之唾液 如琺瑯質)。細菌似乎藉產 二蛋白上(例 的附著以附著至口腔表面。隨後卜 於達成一特定密度之後,據: Γΐ 成柱狀物及不規則表面結構。再者, 物涛膜基質據信具有形成附著至第一層錯合細菌之細 叢之多層及歧異菌種之複雜結合。 、^ 里又制於任何特殊理論,—般相信,抗附著口内 之機制為抗附著劑與細菌本身交互作用而使 ,面之其他部分之交互作用(其通常會促進與口 面之%體或其他部分聯結)。 _1]另-種抗附著機制為藥劑與口腔表面交互作用 二=一保護層’使細菌及生物薄臈成分無法附著至口 牙齒表面’藉此避免初始錨合層形成於口腔表面。此 =?:]可實質上覆蓋口腔表面及避免細菌及其他生 /1杜土質之成分的附著。雖然不欲設限本發明之作用為 壬’殊機制,但相信本發明之許多具體例之矽氧烷聚合 200810786 物活性劑係藉由此一機制作用,即塗 表面能量及抑制細菌附著。 设牙表面、改變其之 [0022]因此’雖然不欲限制於任—特 為活性成分之包含具有親水區(例如含•分) 之口用濩理組成物係藉由實質上抑制細菌附著至 : 作二所謂’’實質上抑制”意表生物 :及 =面生的程度視活性成分於活體中被遞;; == 分佈以及在以活性成分處理之前所存在 改變硬㈣(ίΓΓ具有親水區之石夕氣垸聚合物顯示可 =避免或降低可能在牙表面上形成牙菌斑生 1= 且有•:附:及黏附。較佳之矽氧烷聚合物在牙齒表面上 降低:生物:請著一段充分時間以有效地避免或 膜形成。|或附者至牙表面’藉此避免或降低生物薄 及二具中,口用組成物包含-種抗_ 石夕氧燒聚合物,其據信為一種實質 之 ==薄=!附著劑。親水區包含-部分體,選:面由々 組群中。、此酸酉旨、/鼻脂、胺類及其之組合所成 成物中被避、矣日士氧、元來合物尤其包括前述者。當於口用組 須額外的in ’ ”燒聚合物之效能為充分的’使得無 實質上如’於某些具體例中,口用組成物為 ”曰丨活性成分,諸如鹵化二苯醚、桉葉油酚、 13 200810786
百里酴、薄街細專。就此點言之’組成物具有高度抗牙菌 斑效能,僅需較少的活性成分,彼等可能為昂責且複雜調 配的。所谓實夤上不含’’意表成分或化合物缺乏的程度為 無法被偵測到或疋為其之期望目的(若期望之特性或特質 的缺乏被要求者)仍適合使用此述語。於某些具體例中, 實質上不含意表低於約3重量%之非離子性或親脂性活性 成分,選擇地低於約2%,選擇地低於約1%,較佳完全不 含活性成分。於某些具體例中,口用組成物實質上一 種抗牙菌斑及/或抗酒石活性成分(其為包含至少一個親 水區之矽氧烧聚合物)所組成。 [0024]此種口用組成物可選擇地包含其他於口用组成 物中較不複雜調配或提供特別理想之口内護理利益之活性 成分,例如聚磷酸鹽抗結石化合物或抗齲齒 =詳細料。於某些制财,口隸絲包含抗牙; =二其實質上係由具有至少-個親水區之嫩 产下予具體例中,此—抗附著效果係在相當低濃 得。例如,口用組成物包含-種活性成分,其 ;、舌Λ;或多個親水區之矽氧烷聚合物’以約0.001至約 L成Γ;’尤佳介於約〇.5至約2.5重量%之量存在於口用 之且右―、於某些具體例巾,組成物包含約1重量% /、—或多個親水區之矽氧烷聚合物。 聚八多具體例,具有包含帶有親水區之彻 /卜成/刀之口用組成物(如本發明之許多具體例 200810786 =f供者)之應用’與許多在含水口腔中被沖洗掉之其他 抗微生物成分相較之下,在低濃度下可促進較長及較有效 的抗牙斑利益。此種牙菌斑的減少接著將提供牙石或酒石 控制。 [〇们7]於許多具體例中,高度有效之抗牙菌斑及抗牙石 口用護,組成物包含具錢水區之々氧烧聚合物作為唯一 的抗牙囷斑/抗菌成分。惟,於某些具體例中,一或多種 •其他活性成分可被包括於口用護理組成物中。任何與矽氧 烷聚合物一起使用之其他活性成分應小心選擇。若添加, 其他活性成分不應與矽氧烷聚合物藥劑反應或減低其之效 能及生物可利用性。 =028]用於口用組成物之口内護理活性成分之非限制 性實例包括例如牙潔白劑、抗微生物劑、抗齲齒劑、抗酒 石劑,抗牙菌斑劑、抗黏附劑、去敏感劑、消炎劑、臭味 控制劑、香料、|色劑、抗老化劑、唾液刺激劑、牙周活 • }±物凋理劑、保濕劑(包括潤膚劑、閉鎖劑及濕潤劑) 天然萃取物及精油、營養素、酵素、蛋白質、胺基酸、維 生素、止痛劑、抗生素及其之混合物。其中可用於本發明 之例示的口内護理活性物被揭示於Nabi等人之美國專利案 4:894,220 ;均為 Gaffar 等人之 5,288,彻及 5,776,435、£卿加 等人之5,681,548 ;全為stringer等人之5,912,274及 5,723,500 ; Durga 等人之 6,290,933 ; Lawlor 等人之 6,685,921 及Doyle等人之美國專利申請公開案第2〇〇3/〇2〇6874中。此 外,許多供口内及個人護理組成物之適當個的活性成分被 15 200810786 列於Gottschalk等人所編之國際化妝品成分辭典與手冊,第 10版,第3冊(2004)中。此等活性成分為熟悉此項技藝者 所熟知者。
[0029]其他口内護理活性成分之混合物(即使在相同分 類之内)為本發明所思及。於許多具體例中,其他活性成 分包含以口用組成物之重量計約0 0001%至約1〇%,較佳 約0.001%至約5%,尤佳約001%至約3%,端視活性化 合物之濃度及口用組成物之形式而定。 [0030]於許多具體例中,較佳地,其他活性成分 雜或非離子性的。惟,就某些具體例而言,非離㈣= 菌劑選擇地被含括於σ用組成物中,a包括苯紛及/或雙 酚化合物,諸如鹵化二苯醚,包括三氯生(2,4,4,-三氯_2^_ 醚)、三氯卡苄(—η) (3,4,4_三氯碳醯苯 )、本虱基乙醇、苯甲酸酯及碳醯苯胺類、苯酚、百里 齡)桉葉油紛、己基間笨二…,亞甲基雙(4_氣_6 某生成分亦可選擇性地包含陽離子活性成分。於 體了:、曰’矽乳烷聚合物包含-種陰離子基團或部分 :合=:;==广分,因為此等陰離子 物:r具體例中,包含陰離子二= 合物)有懸垂含磷部分體之陰離子矽氧烷聚 貝貝上 >又有險離子活性成分。 ]准於其他具體例中,陽離子活性成分可適合用 16 200810786 於本發明,特別是當矽氧烷聚合物僅為中等陰離子性或陽 離子活性物僅為稍微陽離子性時。於許多具體例中,適當之 陽離子活性物包括例如季銨化合物,諸如氯化苄烷鐫、苄索 氯铵(benzethonium chloride ) ; 口比錠(pyridinium)及異 4 鏘 (isoquinolinium)化合物,包括氯化十六基σ比錠;哺咬衍生物, 諸如雙辛氫咬;脎衍生物,諸如羥乙礦酸己脎定(hexamidine isethionate);雙吼咬衍生物,諸如辛尼定(〇(^6111(111^)。其他 陽離子活性物包括胍類,諸如雙_胍納得(bisguanide),包括氣 己替丁(ctilorhexidine)及亞勒西丁(alexidine)。其他為陽離子 性化合物之選擇性活性成分包括Να-醯基胺基酸烷基酯及鹽 類,包括乙基月桂醯基精胺酸酯氣化氫(ELAH)。· [0033]於一些具體例中,其他活性成分包含一種為生物 薄膜破壞劑之口内護理活性物。生物薄膜破壞劑通常為一 種可避免生物薄膜之形成及/或攻擊已在口腔表面上形成 之生物薄膜之化合物且包括可水解蛋白質、殿粉及脂肪(其 形成生物薄膜基質之一部分)之酵素。於某些具體例中, 此等活性成分為酵素,包括例如蛋白酶酵素,諸如胱胺酸 蛋白酶或絲胺酸蛋白酶。實例最理想地係選自組群··木瓜 酵素(例如,由番木瓜(Car/ca papaya)之綠色果實及葉之 乳膠所分離者)、無花果酵素(例如,由熱帶榕屬植物(熱 帶無花果樹之樹膠所分離者)、填蝦酶(例 如,由南極蝦(Antarctic Krill)分離而得者)、其他胱胺酸及 絲胺酸蛋白酶、葡糖澱粉酶、葡聚糖酶、變構水解酶、溶 菌酶、植物脂肪酶、胃脂肪酶、胰脂肪酶、單寧酶、鳳梨 .200810786 :素、凝乳胰蛋白酶、蛋白分解酵素、 :銀侧蛋白酶(gingipain)、葡萄糖氧化酶、彈鐵性蛋蛋白白 酶及/或纖維素酶、果膠酶及彼等之混合物。其他例干之 =腔=薄膜破壞劑包括合成之富組蛋白㈣—、:夫 酮、呋喃酮衍生物及任何上述之混合物。 =其他有用之口内活性成分包括氟離子源,較佳之 =j足以供應约25 ppm至約5,_啊之氟離子 =納^化鉀、氟㈣鈉、氟㈣銨、單㈣酸鈉⑽p) 二鼠化胺,包括歐力氟(olaflur)(N,_十 ί = 適當之錫離子源包括(但不限於)氟化錫、 錫諸如氯化錫二水合物)、焦磷酸錫、有機_ 错、“口甲酉欠錫、乙酸錫、葡萄糖酸錫、乳酸錫、酒石酸 ^ 馱錫、丙一酸錫及擰檬酸錫)、乙二醇化錫等。辞離 2 ’諸如乙酸鋅、次氯酸鋅、檸檬酸鋅、葡萄糖酸辞、 田,鋅、氧化鋅、硫酸鋅、檸檬酸鋅納等亦適合用於口 用組成物中。 = 035]某些類型之有用之抗牙石活性成分為直鍵分子 ,去水合聚磷酸鹽。聚磷酸鹽通常以彼等之完全或部分中 、旧=水可命驗金屬形式(例如_、鈉或銨鹽及彼等之任意 二物)f以應用。因此,可用作抗酒石劑之直鏈分子去 酸鹽化合物包括那些諸如三㈣酸鈉、六偏填酸 r焦磷酸鹽、二驗或四驗金屬焦鱗酸鹽,諸如Ν%ρ2〇7、 4Ρ2〇7、Na2K2P2〇7、Na2H2P2〇7 及 Κ2Η2ρ2〇7,及環狀構酸鹽 200810786 體2三聚鱗酸釣、三偏礎酸納或其之混合物。於許多且 體例中’此種活性成分在力:靈 、夕八 約10%,Μ人 存 度為成物之約請1至 例Ρ广」"於約1至约5%。亦可使用聚碌酸趟作為 =豕庭護理及清潔組成物之活性成分, 地予以說明。 广又更评細 =6]合成之陰離子直鏈㈣酸鹽亦已知 f成刀之效能增進劑,尤其是用來增進口内護理成分^ 抗菌、抗牙石或其他活性劑)之效能。此二 =化,物亦可被用於形成薄膜(如下述)。此種陰離子聚 ,酉夂复通=以彼等之游離酸或較佳為部分或尤佳為完全中 、口之水可溶驗金屬(例如鉀及較佳為納)鹽之形予 以利用。較佳之共聚物為順丁烯二酸酐或酸與另 合之乙烯性不飽和單體之1: 4至4 : !共聚物,較佳為: ^分子量(Ml)約30,_至約5,_,_之甲基乙稀^ 氧乙烯)。一較佳之共聚物為甲基乙烯醚/順丁烯二酸酐。 此等共聚物之實例可得自lsp公司(威尼市,紐澤西, 國)之商品 GANTREZ®,例如 AN 139 (M W.」,_,_)、an 119(M,W.200,000); S-97 醫藥級(M W 15〇〇 〇〇〇)、AN 169(m % 2,000,000)及 AN 179 (M.W· 2,400,〇〇〇);其中較佳之丘綮 S-97製藥級(Μ·W· U〇0,_)。於許多具體例中,若ς成之= 離子聚羧酸鹽被包括於組成物中時,其較佳之存在量為 0.001%至約5重量%。 [0037]唾液刺激劑為另一種傳統之活性成分且包括食 用酸,諸如擰檬酸、乳酸、蘋果酸、琥珀酸、抗壞血酸^ 19 200810786 己二酸、反丁烯二酸及酒石酸及其之混合物。h2拮抗劑為 另一種有用之活性成分。可用於本發明之h2拮抗劑包括西 米替丁(cimetidine)、依汀替丁(etintidine)、雷尼替丁(ranitidine) 、 ICIA-5165 、 替 奥替丁 (tiotidine) 、 ORF-17578 、 魯匹特 替丁(lupititidine)、朵那替丁(donetidine)、費莫替丁 (famotidine)、羅塞替丁(1*〇\3^(1丨1^)、匹芬替丁(口丨£31^出1^)、藍 替丁(lamti- dine)、BL-6548、ΉΜΥ·25271、賽爾替丁(zaltidine)、 尼賽替丁(nizatidine)、麥芬替丁(11^61^出1^)、6!^丫-52368、8尺卜 94482、BL-6341A、ICI-162846、雷米索替丁(ramixotidine)、 Wy-45727、SR-58042、BMY«25405、羅斯替丁(loxtidine)、DA-4634 、 雙 芬替丁 (bisfentidine) 、 硫替丁 (sufotidine) 、 艾 波羅替 丁(ebrotidine)、HE-30-256、D-16637、FRG-8813、FRG-8701、 印波密丁(impromidine)、L-643728、HB-408.4 及彼等之混合 物。可用於本發明之去敏感劑包括檸檬酸卸、氯化鉀、酒 石酸鉀、碳酸氫鉀、草酸鉀、硝酸鉀、锶鹽及彼等之混合 物。 [0038] 本發明之口用組成物除了前述者外,選擇性地包 含其他抗牙菌斑劑/牙菌斑破壞劑,包括(但不限於):銅、 鎂及锶離子源(通常以鹽形式予以提供);二甲基聚矽氧烷 共聚多元醇(諸如鯨蠟基二甲基聚矽氧烷共聚多元醇)、尿 素、乳酸鈣、甘油基磷酸鈣;聚丙烯酸锶及彼等之混合物。 [0039] 於某些具體例中,活性成分為一種消炎劑。某些 有用之消炎化合物包括類黃酮、黃烧類、白菊内脂(parthe-nolide),諸如倍半祐内酯白菊内脂、雄烯二醇(AED)及脫 20 200810786 氫表雄甾酮(DHEA)。其他有用之消炎劑為非類固醇消炎藥 劑(NSAIDs)。有用之NSAIDs之實例包括消炎痛(indome-thacin)、I 比布洛芬(flurbiprofen)、酮洛芬(ketoprofen)、依布 洛芬(ibuprofen)、那波辛(naproxen)、麥可芬那酸(meclofenamic acid)及彼等之混合物。其他可用於口内護理活性劑之適合 的消炎劑包括奥勒崗(oregano)萃取物(例如來自奥勒崗 (Origanum vulgare),俗稱為”奥勒崗”、”野生奥勒崗”或“野生 馬約蘭”之萃取物,如Worrell等人於2005年10月24日申 請之美國專利申請案序號11/256,788中所揭示者)或木蘭 萃取物,衍生自木蘭科植物,諸如厚朴從 ,諸如描述於Gaffar等人於2005年11月23日之 美國專利申請案序號11/285,809中。另外,除此之外,亦 可使用局部或全身性止痛劑,諸如阿斯匹靈、可待因、乙 醯胺基苯酚、水揚酸鈉或三乙醇胺水揚酸鹽。 [0040] 此外,一種對口用護理組成物而言為安全的適合 消炎劑包含至少一種類黃酮和至少一種黃烧之組合物,此 一實例為UNIVESTIN®,其係由Unigen製藥股份有限公司 (Superior,科羅拉多,美國)所製造。1^1¥£81^^之完全描 述可見於例如Jia之美國專利申請公開案2003/0216481中。 [0041] 可用作活性成分之例示抗氧化劑包括丁基羥基 大茴香_ (BHA)、丁基化經基曱苯(BHT)、維生素A、類胡 蘿蔔素、生育醇(維生素E )、類黃酮、多酚、抗壞血酸(維 生素C )、植物性抗氧化劑、葉綠素、退黑激素、氯化物、 鈣、氧化鈣、氣化鈣、泛醌二鈉(輔酶Q10)、乙基己基沒食 21 200810786 子酸鹽、過氧化氫(亦可用作潔白劑)、碘、蕃茄紅素、抗 壞血酸鎂、亞硫酸鉀、亞硫酸氫鈉、硫代乳酸及其之混合 物。此等活性成分亦被用於個人護理及清潔組成物中。 [〇〇42]於某些具體例中,組成物包含為抗生素之活性成 分,諸如安滅菌(augmentin)、安莫西林(amoxiciiiin)、四環 素、復力黴素(doxyCycline)、美諾四環素(min〇cycline)、麥 特尼唾(metronidazole)、新黴素(心〇111}^11)、卡那黴素(]^|1-
amycin)及林達黴素(Hncjamycin) ·,及彼等之混合物。 々[0043]適§之言養素包括維生素、礦物質、胺基酸及彼 等之混合物。維生素包括維生素C&D、噻胺、核黃素, 泛酸鈣、菸鹼酸、葉酸、尼古丁醯胺、吡哆醇、氰鈷维生 素、對-胺基苯甲酸、生物類黃酮及彼等之混合物。營養性 補充πα包括胺基酸(諸如L_色胺酸、丄_離胺酸、甲硫胺酸、 蘇胺酸、左旋肉酸及L_肉酸),抗脂肪肝劑(諸如膽鹼、 肌醇、甜菜驗及亞麻油酸),魚油(包括其之成分,諸如^ 3 (N-3)多元不飽和脂肪酸、二十碳五 酸),及彼等之混合物。 卞一奴,、烯 以=4]二用物較佳以口腔可接受之載劑或媒液予 =供。載劑可為液體、半固體或固體相, 括口牙t、牙粉⑽^ 二)、广、薄膜或任何其他熟悉此 'i:特定載劑成分之選擇視期望之產品形式而定 八為〉糸齒劑形式,諸如牙膏、牙 22 200810786 :及預防,膏、糖果(包括膠質、球珠及咀嚼膠)、薄膜、 k抹式產ΠΠ、專業磨光調配物或任何其他此蓺 所熟悉之形式。
[]於斗夕具體例中,用來製備口用組成物之口腔可 接又之4㈤劑載劑包含水相。可被用來形成上列載劑之傳 統成分為精於此技藝者所熟知者。誠如熟悉此項技藝者所 知悉’除了則述該等成分外,σ用組成物選擇性地包括其 他物貝包括例如表面活性的藥劑,諸如表面活性劑、乳 化劑及泡沫調節劑、黏度修飾劑及增稠劑、濕潤劑、稀釋 d pH /周整劑、潤膚劑、保濕劑、口感劑、甜味劑、香 味劑、著色劑、保存劑、溶劑(諸如水)及彼等之組合。 應瞭解雖然上述物質類別之—般屬性可能不同,但可 性,且任何特定物f可在兩或多類此等類別物 貝内充作夕重目的。較佳地’此等載劑物質係選擇與所有 之活性成分(包㈣氧烧聚合物)及任何其他經選擇供口 用組成物之其他活性化合物之組份相容及穩定者。 [0047]典型之有用的表面活性藥劑被揭示於以上所夂 照及論述之參考文獻中,包括於美國專利案第4,請㈣ 號及Worrell之美國專利申請案第11/256,788號巾。表面 活性藥劑通常為π用組成物之重要方面,因為彼等可充作 表面活性劑、,乳化劑、泡沫調整劑及/或活性成分之分散 劑。例如,當口用組成物具有包含陰離子活性成分之活性 成分時’較佳載劑包含非強力陽離子性之表面活性劑,使 陰離子化合物可結合至會潛在降低其之生物可利用性之陽 23 200810786 離子活性成分。視石夕氧 I中所代表之…2基之相二;, 有陰離子部分或特性。因此,於某些具體=燒f合物具 聚合物具有陰離+ # 」中,當梦氧烧 、们在離子特性時,較佳 之表面活性劑’諸如強力陽離子表面活性^: 3料目谷 [0048] if ^ y ^ σ ^ ^ ^ φ ^ if± ^ ΐ二=相當穩定者。此等化合物為== 基及Ν·棕櫚醯基肉胺 ()Ν-肉豆寇醯 20(聚氧乙、M (例如聚山梨糖醇酯 (承乳乙抑20去水山梨糖醇單月桂酸醋,丁 聚山梨糖醇酯80 (聚氧乙烯20去水山学糖醇& TW麵⑧80)、普洛斯莫⑽〇xa贿s) /可^早= =二:ri例如椰子酿胺基兩基甜菜驗及月桂醢胺 =丙基甜朱驗)、及兩性有機合成清潔劑。於活 之具體例中’表面活性藥劑較佳係選自由; 非離子性表面活性劑、陰離子性表面活性劑 性劑或彼等之混合物。於某些具體例中,一 λ ' 性筚添彳以的π nn 1 〇/ s 或夕種表面活 之可:吏用任何適當之香味劑或甜味劑物質。適合 :!味ί:之實:為香味油’例如荷蘭薄荷、胡椒薄荷、 η 丁香、鼠尾草、由加利樹、馬郁桂、 #板、來姆、柳撥、葡萄柚及水揚酸甲酿 24 200810786 如溥荷醇、香芹酮及茴香醚之化學品。冬 蔗糖、乳糖、麥芽糖、山梨糖醇、木糖醇 J匕括 紫蘇糖、AMM天門冬胺酸苯丙胺酸甲 納、 上所述,於某些具體例中,π用組成物實 === ::諸如親脂性香味劑。惟,於某些具體;二 味劑可分別或-起被組合於口腔組成物中,濃度 至約5%,較佳約〇·5至約1.5%。 :、、'、、、、 ·
[0050] 於口用組成物為漱口水形式之 中 載劑為實質上液體。術語"漱口水” ^」中:例不之 沖洗劑等。於此一製備中,口内可::水、噴霧劑、 相’包含水或水和醇混合物。此外,常具有水 [0051] 於口腔組成物為糖果形式之且二細1。 劑為實質上固體或半固體。糖果載劑為::丨蓺中二]示之載 包含-種非-致_性載多,二含^ 化劑、潤滑劑、香味劑、二及:或…糖衍生物)、乳 咀嚼膠载劑通常具有咀嚼^美=二及選擇性之塗覆材料。 味劑及一種香味劑。 7 _ 戈夕種塑化劑、一種甜 [0052] 於口腔組成物 劑為實質上固體或半固體、^式之具體例中,例示之載 溶或可分散之相形’此等薄膜载劑包含水可 薄膜載劑亦可包含疏水性^親水性聚合物。選擇性地, 層或與親水性薄膜形成取^膜形成聚合物,成為可移動背 成〜物混合。薄膜載劑選擇性地包 25 .200810786 ^浦㈣ '填料 '增量劑及減修_劑。 劑、濕潤劑、黏度修飾劑及句 S /舌性藥 如水)、香味劑及甜味劑。'研磨劑、溶劑(諸 =054]於許多具體例中’ 口用組成物被提供於 八 或相中。於其他具體例中,口早成刀 ::及第二成分。維持成分分開僅需要諸成 與:用t成物之另一成分交互作用的 夕· 、 、 雙成分口用組成物被應用於有_咬 =不相容成分被含括於口用組成物中之處。例如有: ,成分包含具有陰離子特性之石夕氧燒聚合物成分 = =維持陽離子性化合物與強力陰離子性成分分開。成= /刀離可經由此技藝中已知或將被發現的方法予以完成… ^匕學、物理及機械之分離方法或此等之任意組合。例^ 弟一及第二成分可予以組合’但某些成分可藉包覆或包封 —或二者於薄膜、塗料、膠囊、膠質粒子等中予以分開 持0 、、 立[〇〇55]因此,上述口用護理組成物之許多具體例中之任 思者可接觸或規則地塗抹至口腔表面,較佳至少—天一 次,尤佳一週多天,最佳以長期每日為基礎。 [〇〇56] 口用組成物可藉適當混合諸成分予以製備。例 如,於製備漱口水中,矽氧烷聚合物被分散於含水溶劑及 /或醇中,然後予以添加至濕潤劑、表面活性劑和水1混 26 .200810786 合物中。形成之漱口水產品隨後被包裝。 [0057]潔齒劑通常藉添加不同之鹽類(包括氟化物鹽, 當被含括於組成物中時)及甜味劑(例如糖精)及任^水 可溶口内護理活性成分化合物至水中,於該處予以混合。 於另一容器中,所有之濕潤劑、膠質及聚合物(包括ς氧 烧聚合物)可被添加在—起。上述以水為底之混合物與濕 潤劑、膠質及聚合物一起被添加至容器中。组合八壁 擇地被加熱至—大於約赋之溫度,例如約^至^^ C ’以分散膠質及聚合物。隨後冷卻經加熱之混合物至低 於約38°C (約100Τ)。然後將混合物與研磨劑缸合,盆中 其於真空下被高速混合約15至約2G分鐘。混合任何香味 油及親脂性π内護理活性成分。將此混合物混合至上述以 混合物中,於該處其在高速及真空下被混合直到 ^刀分政為止。添加表面活性劑並再度將混合物混合以分 ::::氧烷聚合物可選擇性地與表面活性劑一起添加, 而不疋被添加於聚合物相中。 成^8], 〇用組成物可被混合於糖果及脫普(trope)中。形 例!1 口香糖)或脫# (例如键劑)之方法為此技 孰知者’且可藉攪拌其他口内護理活性化合物 ::骖基或塗覆膠基(尤其例如膠桐、橡膠乳膠、乙烯 妒化添ί 2表面予以製備’理想的是帶有傳統之塑化劑或 或其他甜味劑或碳氮化物(諸如葡萄糖、山梨 摘#)。較佳地,石夕氧烧聚合物被添加至膠基中。 [0059] #口用組成物為薄膜形式時,其可藉任何許多傳 27 200810786 、:的方法予以形成,諸如傳統擠製或溶劑鑄造 / 為稭溶劑鑄造製備一種薄膜,可將薄膜形成聚 合物溶解於與聚合物相容之充分量之溶劑 液後,於攪拌中添加塑化劑,並 ★相釕 ΓΟί:均句溶液為止,接著添加活性成分,包括 2:: 5物’表面活性劑、增量劑及任何其成分,諸如 ==甜味劑。為易於使用’乾燥薄膜可被切成適當尺寸 /狀之碎片並予以包裝於一適當容器中。 【實施方式】 ’二0::?下實施例進一步描述及說明本發明所思及之 汗多具體例。 物[0 0各61 自]勺根,㈣之許多具體例製備三種口用組成 不同之具有親水部分之錢垸聚合物。兩種 二為:且成物A”和”組成4勿B”之組成物包含具有含碟部分 矽乳烷聚合物,亦即分別為PEC0S⑧ PEC〇SIL®PS_1〇〇 W()0 及 气工^ A 、、且玖物L包含一種具有聚氧乙烯和聚 =之含親水性部分之石夕氧烷聚合物’亦即1XM90。此 5物各自被完全描述如上。組成物A、b及c係利用 :I所列之成分予以製備。被包括於組成物中之其他活性 2為焦磷酸四鈉(一種抗結石活性成分)及氟化鈉(抗 齲齒活性成分)。 28 200810786 含矽酮之牙膏調配物(重量 組成物
3,0 0.6 0.5 適量 0.243 53.9 0.3 25.5 1.2 1,00 0.16 0.72 c
0 0 100
齒[二二具;r—個親水區^^潔 口腔中的抗牙斑活性。口用組成物被應用至 抑制牙菌斑形:、二:匕且促進整體口腔健康’包括 用組成物包含具有二χ、牙周㉟、齲齒等。例如,當口 用組成物可有;妯永:個親水區之矽氧烷聚合物時,口 細菌之生長;菌斑形成及在口腔表面各種口内 少-種_·抗酒石Ί二口用組成物運-步提供至 29
Claims (1)
- 200810786 十、申請專利範圍: 包含一種具有含磷部分之矽氧烷 i一種口用護理組成物 聚合物。 2. 根據申請專利範圍第1項之組成物,其中至少一種含鱗 部分係選自由:磷酸酯、膦酸酯、磷脂、含磷酸酯 及其之組合所成組群中。 3. 根據申請專利第丨項之組餘,其切氧垸聚合物包含一種具有下式之化合物: ch3 ch3 H3C-SiO 乂 S ch3 ch3 己h3 ch3 r1—r2 ch3 Si—CH〇 I ch3 其中Ri係選自由:烷基、芳基、醯胺基、酯、吡咯啶酮、 乙烯基、丙烯酸酯基、矽氧烷、胺基甲酸酯、碳酸酯、 乙烯醇、氧化烯及其之組合所成組群中;r2包含一選自4 由.碍酸酯、膦酸酯、麟脂、含填酸酯基團及其之組合 所成組群中之部分,’’X,,為〇至100及”y”為1至10〇。口 .根據申請專利範圍第3項之組成物,其中&具有式: _(CH2)v-(q)z,其中Q為至少一基團,選自:、 C3H60 ; CH2CH(0H) ; C0NH、C02、NH、C0NH、 Ο其中”v”及”z”為1至16。 •根據申請專利範圍第!項之口用護理組成物,其包含約 0.001至約3重量%之矽氧烷聚合物。 6.根據中請專利範圍第}項之組成物,纟中·组成物包含一 30 200810786 成分,選自由··表面活性劑、黏度修飾劑、增稠劑、濕 潤劑、稀釋劑、填料、pH調整劑、塑化劑、填料、纖、 組織修飾劑、香味劑、甜味劑、著色劑、保存劑、溶劑 及彼專之混合物所成組群中。 7·=據申請專利範圍第i項之組成物,另包含一種活性成 刀,選自由抗微生物劑、抗酒石劑,抗牙菌斑劑、抗齲 ^ 4、生物薄膜破壞劑、抗氧化劑、消炎劑、牙齒潔白 ⑩ 1丨抗黏附劑、去敏感劑、臭咮控制劑、香料、著色劑、 抗老化劑、唾液刺激劑、牙周活性物、調理劑、天然萃 取物、精油、營養素、酵素、蛋白質、胺基酸、維生素、 止痛劑、及其之混合物所成組群中。 8·、種包含具有含磷部分之矽氧烷聚合物之口用護理組 成物其中矽氧烷聚合物為一種實質上抑制細菌於牙齒 表面上形成生物薄膜之抗附著劑。 9·根據申請專利範圍第8項之口用護理組成物,其中含碟 部分係選自由··磷酸酯、膦酸酯、磷脂、含磷酸酯基團牛 及其之組合所成組群中。 10. 根據申請專利範圍第9項之口用護理組成物,其中 烷聚合物包含一種烷基磷酸酯矽氧烷。 11. 根射請專利範圍第9項之口用護理組成物,其中 烧聚合物包含一種聚二甲基石夕氧燒磷酸醋。 12. 根據中請專利範圍第8項之σ用護理組成物,其中 烷聚合物包含一種具有下式之化合物: 31 200810786 9h3 ch. H3c—|ίΟ^|ι.〇)^|!.〇)^|—CH3 ch3 ch3 r^~r2 ch3ch3 ch3 其中Ri係選自由:烧基、芳基、臨胺基、酯、吡嘻σ定酮、 乙烯基、丙烯酸酯基、矽氧烷、胺基甲酸酯、碳酸酯、 乙烯醇、氧化烯及其之組合所成組群中;及1包含一選 自由·磷酸酯、膦酸酯、磷脂、含磷酸酯基團及其之組 合所成組群中之部分,’,X”為0至100及”y”為1至100。 13·根據申請專利範圍第i 2項之口用護理組成物,其中R1 具有式:_(CH2)v-(Q)z,其中Q為至少一基團,選自:QHf、C3H60 ; CH2CH(OH) ; CONH、C02、NH、CONH、14·根據申請專利範圍第8項之口用護理組成物,其中矽氧 烧聚合物包含一種具有下式之化合物·· CH3 CH3 II 1 H3c——SiO 乂 CH3 ch3 Si-O^Si-O) CH3 CH3 i(〇C2H4)(OC3H6)-R ch3I Si—CH3 I ch3 其中 R2 為-P03H2 或-(CH3CH2H30)np〇3H2 100,ny”為 1 至 100 且”m”為 〇 至 15。 ’’X”為0至 15·根據申請專利範圍第8項之口用護理組成物,其中石夕氣 烷聚合物包含一種具有下式之化合物: 32 200810786 f 3 ch3 ch3 I Hs H3C—rr呷、CH3 〇 CH3 CH3 CHrCHrCH2-NCr 〇4、 Nt 人 〇/為〇至100且,y,為l至100 其中r3為烷基 用護理組成物,其中r3 其包含約 另包含一 抗牙菌斑 消炎劑 16·根據申請專利範圍第15項之 為c18烷基。 ' 17. 根據中請專㈣圍$ 8項之口賴理組成物 0.001至約3重量%切魏聚合物。 18. 根據申料職圍第8項〇賴理組成物 胺基酸 另包含 增稠劑 種活性成分’選自由抗微生物劑、抗酒石劑 劑、抗鹤齒劑、生物薄膜破壞劑、抗氧化劑π :齒潔白劑、抗黏附劑、去敏感劑、臭味控制劑、香;、 著色劑、抗老化劑、唾液刺激劑、牙周活性物、調理、 天然萃取物、精油、營養素、酵素、蛋白質 月 維生素、止痛劑、及其之混合物所成組群中 19. 根據申請專利範圍第8項之口用護理組成物 載劑成分’選自由表面活性劑、黏度修飾巧 濕潤劑、稀釋劑、ΡΗ調整劑、潤膚齊卜“齊;二感 劑、甜味劑、香味劑、溶劑、水、著色劑、保存劑及彼 33 200810786 荨之混合物所成組群令。 2〇·種口用組成物,包含抗牙菌斑、 分,:M:冬古 n Q $抗酒石活性成 :3有_種具有至少—個親水區成 其中石夕氧燒聚合物為—種實 形成生物壤贈〇 裡貝貝上抑制細囷於牙齒表面上 親脂性活性成^附著劑’且其中組成物為實質上不含 21. :據Γί!利範圍第20項之口用組成物,其中親水區包 人.乳化烯類、⑽S旨、膦酸S旨、磷腊、胺類 及/、之、、且5所成組群中之部分。 、 22. 根據巾請專利範圍第2 〇項之σ用組成物,其中 η 合物包含一種具有下式之化合物: 兀來 ch3 ΪΗ3 IHs IH3 iiCH H3C—f0,·0叶< \Ch3 CH3 CH3 c3H60(C2H40)m(CH3C2H30)nR4 其中R4係選自H或-P〇3H2,”X,i為〇至1〇〇,,,y,,為j至 100且”m”為〇至15,及”n"為0至15。 23·根據申請專利範圍第20項之口用組成物,其中石夕氧ρ | 合物包含一種具有下式之化合物: ch3 ch3 ch3 ch3 I I I I ^/SiCHs H3C~SiO^Si.〇^S«.〇% \CH3 CH3 CH3 〇3^6〇(〇2Η4〇)^|Ρ〇3Η2 其中”x"為0至100,”y”為1至100且”m,,為〇至15。 34 .200810786 24.根據申請專利範圍第2G項之口用&成物,其中 合物包含一種具有下式之化合物: 凡來 ch3 ch3 ch3 ch3 h3c一『0弋|卜。)^(『0)^-1—ch3 CH3 CH3 R,-R2 CH3 „系選自由:烷基、‘芳基、醯胺基、醋、吼略啶酮、 乙卸基、旨基、$氧烧、胺基?酸§|、碳酸 乙烯醉、氧化烯及其之組合所成組群中;及R2包含一選 自由W馱®曰、膦酸酯、構脂、含磷酸酯基團及其且 = 中之部分’ ”X”為0至100及V為1‘^ .根據申°月專利乾圍第20項之口用組成物,其中石夕氧燒产 合物包含一種具有下式之化合物: 兀 ch3 ch3 ch3 ch3 H3c—SiO^Si-O^ShO)-—Si—CH3I I x y I CH3 ch3 ch3 m(OC2H4)(OC3H6)—R2 其中 R2、403H2 或-(CH3CH2H30)nP03H2,,,x,,為 〇 δ υ y為1至100且”m"為0至15。 26.根據申請專利範圍第2〇項之口用組成物,其中矽氧烷聚 合物包含—種具有下式之化合物: 35 200810786 Η其中R3為C18燒基,,,χ,,為0至100且”y"為1至100。 27·根據申睛專利範圍第2〇項之口用組成物,其包含約 〇·〇〇1至約3重量%之矽氧烧聚合物。 28·根據申凊專利範圍第2〇項之口用組成物,另包含一種非 親,性活性成分,選自由抗齲齒劑、生物薄膜破壞劑、 =氧化劑、消炎劑、牙齒潔白劑、抗黏附劑、去敏感劑、 ΐ = 、香料、著色劑、抗老化劑、唾液刺激劑、 素、蛋白質天^举取物、精油、營養素、酵 所成組群中。 止痛劑、及其之混合物 36 200810786 七、指定代表圖: (一) 本案指定代表圖為:第(無)圖。 (二) 本代表圖之元件符號簡單說明:無八、本案若有化學式時,請揭示最能顯示發明特徵的化 學式: 無 4
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79638406P | 2006-05-01 | 2006-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200810786A true TW200810786A (en) | 2008-03-01 |
Family
ID=38606500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096115215A TW200810786A (en) | 2006-05-01 | 2007-04-30 | Oral compositions comprising siloxane polymers |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9649513B2 (zh) |
| EP (1) | EP2024037A2 (zh) |
| JP (1) | JP2009535415A (zh) |
| CN (1) | CN101437578A (zh) |
| AR (1) | AR060739A1 (zh) |
| AU (1) | AU2007248220A1 (zh) |
| BR (1) | BRPI0710985A2 (zh) |
| CA (1) | CA2649485A1 (zh) |
| MX (1) | MX2008013614A (zh) |
| MY (1) | MY157914A (zh) |
| RU (1) | RU2008147144A (zh) |
| TW (1) | TW200810786A (zh) |
| WO (1) | WO2007130841A2 (zh) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1811944B1 (en) | 2004-11-16 | 2010-09-08 | 3M Innovative Properties Company | Compositions including a caseinate treated dental filler |
| JP5548121B2 (ja) | 2007-05-14 | 2014-07-16 | リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | バイオフィルム中の細菌細胞における生理学的分散応答の誘導 |
| CA2728568C (en) * | 2007-07-11 | 2019-04-23 | Karen L. Albert | Composition and packaging method for animal dental care |
| US20100022471A1 (en) * | 2008-07-23 | 2010-01-28 | Sage Products Inc. | Oral Moisturizer for Alleviating Dry Mouth |
| TWI404544B (zh) | 2008-08-11 | 2013-08-11 | Colgate Palmolive Co | 含珠粒之口腔保健組成物 |
| US8790707B2 (en) | 2008-12-11 | 2014-07-29 | 3M Innovative Properties Company | Surface-treated calcium phosphate particles suitable for oral care and dental compositions |
| WO2010114546A1 (en) * | 2009-04-02 | 2010-10-07 | Colgate-Palmolive Company | Dentifrice composition |
| USD667730S1 (en) * | 2010-11-05 | 2012-09-25 | Colgate-Palmolive Company | Container |
| USD667728S1 (en) * | 2010-11-05 | 2012-09-25 | Colgate-Palmolive Company | Container |
| USD647806S1 (en) * | 2010-11-05 | 2011-11-01 | Colgate-Palmolive Company | Container |
| USD647407S1 (en) | 2010-11-05 | 2011-10-25 | Colgate-Palmolive Company | Container |
| USD652318S1 (en) * | 2010-11-05 | 2012-01-17 | Colgate-Palmolive Company | Container |
| MX2013006636A (es) * | 2010-12-13 | 2013-08-01 | Colgate Palmolive Co | Composiciones bucales y metodo para producir las mismas. |
| USD664809S1 (en) * | 2011-04-29 | 2012-08-07 | Ets Express, Inc. | Beverage container |
| USD670134S1 (en) * | 2011-05-02 | 2012-11-06 | Trudeau Corporation 1889 Inc. | Container with a cap opener |
| USD687677S1 (en) * | 2011-05-19 | 2013-08-13 | Patricia Kim Sturgess | Water bottle |
| USD718572S1 (en) | 2013-08-12 | 2014-12-02 | Patricia Kim Sturgess | Water bottle |
| SG11201802933YA (en) * | 2015-10-07 | 2018-05-30 | Joel Huizenga | Resetting biological pathways for defending against and repairing deterioration from human aging |
| MX2018011989A (es) | 2016-04-01 | 2019-02-13 | Procter & Gamble | Composiciones para el cuidado bucal que contienen una fase de red de gel. |
| USD805079S1 (en) * | 2016-06-22 | 2017-12-12 | Amazon Technologies, Inc. | Scanner device |
| US11141873B2 (en) | 2017-04-18 | 2021-10-12 | The Gillette Company Llc | Shaving razor system |
| USD885839S1 (en) * | 2018-05-09 | 2020-06-02 | b.box for kids developments Pty Ltd. | Drink bottle |
| CN113546033A (zh) * | 2021-07-29 | 2021-10-26 | 广东真丽斯化妆品有限公司 | 一种促进微生态平衡益生菌复合物及其制备方法 |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1050339A (zh) | ||||
| US2735590A (en) | 1956-02-21 | Combined closure and valve operating | ||
| US2753214A (en) | 1954-01-29 | 1956-07-03 | Frederick G Lodes | Foam dispensing head for aerosols |
| US3089624A (en) | 1956-06-28 | 1963-05-14 | Leeds & Micallef | Pressure discharge container |
| US2954904A (en) | 1958-10-13 | 1960-10-04 | Joseph B Potoczky | Gas pressure type dispensing container cap |
| US2963265A (en) | 1958-10-29 | 1960-12-06 | Cornell Valve Corp | Dispensing mechanism |
| GB1051551A (zh) | 1963-03-25 | |||
| US3312723A (en) | 1964-08-07 | 1967-04-04 | Johnson & Son Inc S C | Actuator cap |
| US3317092A (en) | 1965-06-23 | 1967-05-02 | Avoset Company | Center-push lever release mechanism for aerosol valves |
| US3510029A (en) | 1968-03-11 | 1970-05-05 | Sterling Drug Inc | Over-cap with molded trigger and air seal cap for the spray orifice |
| US3712515A (en) * | 1969-01-13 | 1973-01-23 | J Corll | Child-safe aerosol spray container |
| US3610479A (en) | 1970-03-23 | 1971-10-05 | Risdon Mfg Co | Dispensing cap with tamper-resistant actuator |
| US3749286A (en) | 1970-11-09 | 1973-07-31 | Colgate Palmolive Co | Actuator cap with actuation disabling means |
| US3785528A (en) | 1972-08-21 | 1974-01-15 | Vca Corp | Aerosol dispensing device |
| US3792802A (en) | 1972-09-11 | 1974-02-19 | K Gores | Aerosol-can dispensing cap |
| US4203552A (en) | 1978-09-05 | 1980-05-20 | Ethyl Corporation | Pressurized atomizer |
| BG27674A1 (en) | 1978-11-06 | 1984-12-16 | Khavezov | Atomic absorbtion non- flame method for determining phosphor in graphite furnace |
| DE2929073A1 (de) | 1979-07-18 | 1981-02-05 | Hilti Ag | Handgeraet zum eintreiben von werkzeugen oder befestigungselementen in werkstuecke |
| US4277004A (en) | 1979-10-15 | 1981-07-07 | Barlics John J | Cover and aerosol activator for aerosol spray can |
| US4373602A (en) | 1980-03-06 | 1983-02-15 | Honda Giken Kogyo Kabushiki Kaisha | Power unit suspension system for motorcycles |
| GB2076728A (en) | 1980-05-21 | 1981-12-09 | Midland Ross Corp | Extrusion devices and methods of reclaiming scrap plastic material |
| USD308474S (en) | 1986-04-15 | 1990-06-12 | Risdon Corporation | Combined dispenser and cap therefor |
| FR2598392B1 (fr) | 1986-05-09 | 1988-08-26 | Oreal | Conditionnement pour deux recipients pressurises |
| US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
| US5288480A (en) | 1987-01-30 | 1994-02-22 | Colgate-Palmolive Co. | Antiplaque antibacterial oral composition |
| USD317253S (en) | 1988-10-06 | 1991-06-04 | Mb Group Plc | Pump dispenser |
| USD324491S (en) | 1988-11-16 | 1992-03-10 | Mb Group Plc | Dispenser |
| FR2639259B1 (fr) | 1988-11-21 | 1991-03-29 | Oreal | Embout pour distribuer un produit, en particulier un produit moussant |
| US5078988A (en) * | 1988-11-28 | 1992-01-07 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Dentrifrices including modified aminoalkyl silicones |
| ES2053962T3 (es) * | 1988-11-28 | 1994-08-01 | Unilever Nv | Dentrificos conteniendo amino alquil siliconas. |
| US4995417A (en) | 1990-04-02 | 1991-02-26 | Precision Valve Corporation | One-piece tire valve adaptor |
| US5070171A (en) * | 1990-06-27 | 1991-12-03 | Siltech Inc. | Phosphated silicone polymers |
| USD335817S (en) | 1990-10-31 | 1993-05-25 | Wella Aktiengesellschaft | Sprayer |
| US5070611A (en) | 1990-11-27 | 1991-12-10 | Stephen Derin | Razor and dispenser |
| AU649639B2 (en) | 1990-12-04 | 1994-06-02 | Yoshino Kogyosho Co., Ltd. | Liquid spraying vessel |
| US5232127A (en) | 1991-10-30 | 1993-08-03 | The Gillette Company | Actuator and hood for dispensing device |
| EP0659804B1 (en) | 1992-09-09 | 1998-12-09 | Kao Corporation | Organo(poly)siloxane modified with phosphoric ester and process for producing the same |
| JPH0692860A (ja) * | 1992-09-14 | 1994-04-05 | Kao Corp | 知覚過敏症治療剤 |
| US5859161A (en) * | 1993-12-06 | 1999-01-12 | Phoenix Chemical | Silicone phosphate esters as irritation mitigants |
| US6225489B1 (en) * | 1993-12-28 | 2001-05-01 | Mona Industries, Inc. | Silicone modified phospholipid compositions |
| US5681548A (en) | 1994-07-15 | 1997-10-28 | Colgate Palmolive Company | Oral formulations |
| US5688496A (en) * | 1994-08-31 | 1997-11-18 | Mona Industries, Inc | Silicone modified phospholipid compositions |
| FR2731211B1 (fr) | 1995-03-03 | 1997-04-11 | Oreal | Dispositif d'actionnement d'un mecanisme de distribution tel qu'une valve equipant un recipient pressurise de type aerosol |
| US5849313A (en) * | 1995-04-12 | 1998-12-15 | Mona Industries, Inc. | Silicone modified phospholipid compositions |
| US6004538A (en) * | 1995-04-28 | 1999-12-21 | The Procter & Gamble Company | Oral compositions |
| US6193958B1 (en) * | 1995-07-05 | 2001-02-27 | The Procter & Gamble Company | Oral compositions |
| US5912274A (en) | 1995-09-22 | 1999-06-15 | Colgate-Palmolive Company | Antiplaque oral composition and method |
| US5723500A (en) | 1995-09-22 | 1998-03-03 | Colgate-Palmolive Company | Antiplaque oral composition and method |
| JPH09157397A (ja) * | 1995-12-06 | 1997-06-17 | Kao Corp | リン酸トリエステル変性オルガノ(ポリ)シロキサン、その製造法、並びにそれを含有する化粧料及び外用剤 |
| USD388319S (en) | 1996-04-02 | 1997-12-30 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Container |
| US20030206874A1 (en) | 1996-11-21 | 2003-11-06 | The Proctor & Gamble Company | Promoting whole body health |
| GB9708182D0 (en) * | 1997-04-23 | 1997-06-11 | Dow Corning Sa | A method of making silicone in water emulsions |
| GB9727366D0 (en) | 1997-12-24 | 1998-02-25 | Unilever Plc | Sprayhead |
| US5975377A (en) | 1998-04-16 | 1999-11-02 | Mcgowens; Helen Marie | Spray deflector cap construction |
| USD423922S (en) | 1998-12-03 | 2000-05-02 | Shiseido Co., Ltd. | Combined spray bottle and cap |
| JP4188535B2 (ja) * | 1999-03-12 | 2008-11-26 | ファイザー・プロダクツ・インク | 口腔用組成物 |
| FR2792913B1 (fr) | 1999-04-29 | 2001-06-01 | Oreal | Dispositif pour l'actionnement d'un organe de distribution notamment une valve, et ensemble equipe du dispositif d'actionnement selon l'invention |
| USD422902S (en) | 1999-06-15 | 2000-04-18 | Shiseido Co., Ltd. | Bottle for lotion |
| USD426773S (en) | 1999-08-13 | 2000-06-20 | Nestec S.A. | Container |
| US6124490A (en) * | 1999-10-26 | 2000-09-26 | Mona Industries, Inc. | Zwitterionic siloxane polymers and ionically cross-linked polymers formed therefrom |
| US6175028B1 (en) | 2000-02-28 | 2001-01-16 | O'lenick, Jr. Anthony J. | Silicone alkyl phosphate esters |
| US6290933B1 (en) | 2000-05-09 | 2001-09-18 | Colgate-Palmolive Company | High cleaning dentifrice |
| DE10023451C2 (de) | 2000-05-12 | 2002-11-21 | Beiersdorf Ag | Sprühkappe für Aerosoldruckgaspackungen |
| JP2001354535A (ja) * | 2000-06-13 | 2001-12-25 | Lion Corp | 口腔用組成物 |
| US6685921B2 (en) | 2000-10-25 | 2004-02-03 | The Procter & Gamble Company | Dental care compositions |
| USD449978S1 (en) | 2000-11-17 | 2001-11-06 | Ulric De Varens S.A. | Perfume container |
| FR2836902B1 (fr) | 2002-03-05 | 2004-05-28 | Oreal | Tete de distribution a canule mobile destinee a equiper un dispositif de conditionnement et de distribution |
| US7928147B2 (en) * | 2002-04-11 | 2011-04-19 | Teva Animal Health, Inc. | Antimicrobial wash and carrier solutions, and uses thereof |
| JP2004107310A (ja) * | 2002-09-13 | 2004-04-08 | Lion Corp | 口腔用組成物 |
| US7028866B2 (en) | 2003-01-31 | 2006-04-18 | S.C. Johnson & Son, Inc. | Pressurized plastic bottle for dispensing an aerosol |
| USD486387S1 (en) | 2003-04-18 | 2004-02-10 | Jetone S. Lee | Translucent cosmetic container with LED illumination means |
| USD490699S1 (en) | 2003-05-05 | 2004-06-01 | The Procter & Gamble Company | Sprayer |
| FR2857342B1 (fr) | 2003-07-10 | 2008-03-28 | Valois Sas | Tete de distribution de produit fluide |
| DE202004008940U1 (de) * | 2004-05-06 | 2005-09-15 | Qualipac Sa | Sprühvorrichtung für Flakon |
| USD511302S1 (en) | 2004-06-10 | 2005-11-08 | Colgate-Palmolive Company | Dispenser |
| USD508414S1 (en) | 2004-06-10 | 2005-08-16 | Colgate-Palmolive Company | Dispenser |
| USD508209S1 (en) | 2004-06-10 | 2005-08-09 | Colgate-Palmolive Company | Dispenser |
| USD508405S1 (en) | 2004-06-10 | 2005-08-16 | Colgate-Palmolive Company | Dispenser |
| USD508411S1 (en) * | 2004-06-10 | 2005-08-16 | Colgate-Palmolive Company | Dispenser |
| USD514944S1 (en) | 2004-06-10 | 2006-02-14 | Colgate-Palmolive Company | Dispenser |
| US7651009B2 (en) * | 2004-08-16 | 2010-01-26 | Warner Lambert Company Llc | Liquid dispensing device |
| DE602006003133D1 (de) * | 2005-06-16 | 2008-11-27 | Oreal | Wässrige Trägersysteme für wasserunlösliche Materialien |
-
2007
- 2007-03-23 US US12/294,321 patent/US9649513B2/en active Active
- 2007-04-26 CA CA002649485A patent/CA2649485A1/en not_active Abandoned
- 2007-04-26 JP JP2009509965A patent/JP2009535415A/ja active Pending
- 2007-04-26 CN CNA200780015710XA patent/CN101437578A/zh active Pending
- 2007-04-26 BR BRPI0710985-7A patent/BRPI0710985A2/pt not_active IP Right Cessation
- 2007-04-26 AU AU2007248220A patent/AU2007248220A1/en not_active Abandoned
- 2007-04-26 WO PCT/US2007/067495 patent/WO2007130841A2/en not_active Ceased
- 2007-04-26 EP EP07761344A patent/EP2024037A2/en not_active Withdrawn
- 2007-04-26 RU RU2008147144/15A patent/RU2008147144A/ru not_active Application Discontinuation
- 2007-04-26 MX MX2008013614A patent/MX2008013614A/es not_active Application Discontinuation
- 2007-04-30 US US11/742,061 patent/US20070253919A1/en not_active Abandoned
- 2007-04-30 AR ARP070101882A patent/AR060739A1/es unknown
- 2007-04-30 TW TW096115215A patent/TW200810786A/zh unknown
-
2008
- 2008-10-10 MY MYPI20084047A patent/MY157914A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR060739A1 (es) | 2008-07-10 |
| WO2007130841A3 (en) | 2008-03-06 |
| RU2008147144A (ru) | 2010-06-10 |
| CA2649485A1 (en) | 2007-11-15 |
| US20090297460A1 (en) | 2009-12-03 |
| US20070253919A1 (en) | 2007-11-01 |
| CN101437578A (zh) | 2009-05-20 |
| AU2007248220A1 (en) | 2007-11-15 |
| EP2024037A2 (en) | 2009-02-18 |
| BRPI0710985A2 (pt) | 2011-05-24 |
| JP2009535415A (ja) | 2009-10-01 |
| US9649513B2 (en) | 2017-05-16 |
| MX2008013614A (es) | 2008-10-30 |
| MY157914A (en) | 2016-08-15 |
| WO2007130841A2 (en) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200810786A (en) | Oral compositions comprising siloxane polymers | |
| TWI429461B (zh) | 製造薄膜及口部照護組成物之方法 | |
| AU2005319647B2 (en) | Anti-caries oral care composition with xylitol | |
| TWI380827B (zh) | 具有交聯聚合物過氧化物之口護理組成物 | |
| CN104853738B (zh) | 含离子液体的口腔护理组合物 | |
| JP4055849B2 (ja) | 歯科治療剤組成物 | |
| MX2007007630A (es) | Composicion para el cuidado oral anticaries con agente quelante. | |
| JP2013501782A (ja) | 口腔ケア組成物 | |
| BRPI0519930B1 (pt) | Composição oral, e, método para inibir e/ou tratar uma condição inflamatória oral em um indivíduo mamífero | |
| US20070254067A1 (en) | Consumer customizable oral care products | |
| JPH08505140A (ja) | 口腔保護組成物でコーティングしたガム | |
| CN104884038A (zh) | 口腔护理组合物 | |
| EP1830821B1 (en) | Two phase toothpaste composition | |
| US10406090B2 (en) | Oral care composition containing ionic liquids | |
| CN103893071A (zh) | 抗菌和抗炎的口腔护理组合物 |